Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-020-03279-7
Abstract: Comorbidity and relative dose intensity (RDI) have been associated with survival in diffuse large B-cell lymphoma (DLBCL) patients, but both relationships remain unaddressed in the same patients. A retrospective review of consecutive DLBCL patients treated… read more here.
Keywords: relative dose; comorbidity relative; cci rdi; comorbidity ... See more keywords
[Chemotherapy for colorectal cancer: Pragmatic assessment of prescription changes and relative dose intensity].
Sign Up to like & getrecommendations! Published in 2017 at "Bulletin du cancer"
DOI: 10.1016/j.bulcan.2017.04.006
Abstract: INTRODUCTION Chemotherapy induced toxicities can generate changes in prescribing and relative dose intensity which have an impact on therapeutic efficacy. METHOD This is a prospective observational study performed in hepato-gastroenterology department for 6 months. All… read more here.
Keywords: colorectal cancer; relative dose; prescription; cancer ... See more keywords
Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective study.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of chemotherapy"
DOI: 10.1080/1120009x.2022.2164116
Abstract: Relative dose intensity (RDI) has been associated with improved survival in patients with advanced solid tumours. However, there is no evidence regarding RDI in patients under long-term treatment with trabectedin for adult advanced soft tissue… read more here.
Keywords: dose intensity; relative dose; trabectedin; pegfilgrastim ... See more keywords
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359211029825
Abstract: Background: Most patients with advanced pancreatic adenocarcinoma (PA) treated with FOLFIRINOX experience adverse events requiring dose reduction. We aimed to assess the association between relative dose intensity (RDI) and disease control in a European setting.… read more here.
Keywords: control; advanced pancreatic; pancreatic adenocarcinoma; disease control ... See more keywords
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022006964
Abstract: Obinutuzumab (G) in combination with chlorambucil (Chl) has been approved in Italy in 2017 as frontline treatment for patients with chronic lymphocytic leukemia (CLL) and comorbidities, following results of the CLL11 trial 1 and real-life… read more here.
Keywords: lymphocytic leukemia; dose intensity; dose; relative dose ... See more keywords
Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15802
Abstract: Background/Aim: Although adjuvant chemotherapy (AC) with S-1 is currently the standard treatment for pancreatic ductal adenocarcinoma (PDAC) in Japan, the associations between its relative dose intensity (RDI) and survival outcomes remain unclear. Patients and Methods:… read more here.
Keywords: rdi; ductal adenocarcinoma; relative dose; adjuvant chemotherapy ... See more keywords